Daniel Eggers
Analyst · BMO Capital Markets
Thank you, Joe, and good morning, everyone. We have a lot of cover today from a finance perspective. We're excited to share our capital allocation plan, which we are confident will create value for our business, our customers and our owners. I'm going to build on Joe's comments by providing more details around our growth projects and cash flows. I will also give an update to our financial outlook as we roll forward our disclosures. But I'll start with our 2022 financial performance. We had a very strong first year financially, earning $2.66 billion in adjusted EBITDA, which exceeded our narrow guidance range of $2.45 billion to $2.65 billion. Our commercial organization had an exceptional year in managing the portfolio, creating opportunities around our fleet and load in a volatile market. Our nuclear fleet performed extremely well during winter storm Elliott, as Joe discussed earlier, and we anticipate being one of the primary recipients of bonus payments. The strong performance from the business was able to offset untimely generation outages, margin shaving and cost pressures we discussed in the third quarter call. The entire leadership team is very proud of how Constellation performed in its first year, both financially and operationally, and I'd like to echo Joe's appreciation to the entire organization for a job well done. We're also introducing 2023 EBITDA guidance of $2.9 billion to $3.3 billion with a midpoint of $3.1 billion, which is up over $500 million from last year's midpoint. I'm going to use the following slide to talk to the key inputs to EBITDA and then free cash flow. Turning to Slide 12. I wanted to talk about the nuclear PTC included in the IRA, which we believe is truly transformational for our company. It provides downside commodity risk protection backed by the U.S. government with unlimited upside to higher commodity prices. It supports unique growth opportunities in clean hydrogen and uprates, it extends the time horizon of our fleet to 80 years and include structural inflation risk protection. Mechanically, the nuclear PTC is designed to provide downside support in the declining price environment, phasing up and down when a plants' market revenues of between $25 and $43.75 per megawatt hour with maximum support of $15 a megawatt hour. This chart shows the illustrative payoff dynamics in 2024. The blue shaded box shows the revenue levels or the PTC support would be available up to the maximum $15 credit when revenues are at $25 and basing down $0.80 on the dollar until you reach $43.75 per megawatt hour, the point in which the PTC value would be 0. With this design, our effective revenues for nuclear plant will be between $40 and $43.75 over a range of revenue starting at $25. Equally important, we retain all of the upside when revenues are over $43.75. So bringing this conversation to life, the green line represents an electricity price above the $43.75 threshold where we would not receive a PTC payment but would collect that price for our power sales, which is consistent with history. The orange line represents a $35 price where we are in the PTC zone and would, in turn, capture $7 PTC because we are below the threshold, bringing the realized revenues to $42 a megawatt hour. Inherent to the drop in power prices in this case, the PTC provides significant downside protection to our business and is a materially positive change from history when facing a lower price environment. We have positioned our portfolio in 2024 to reflect this new dynamic from the downside protection that PTC provides. There are still many unknowns about exactly how the PTC will work that needed to resolve in Treasury's implementation of the legislation. We expect to have this guidance before the end of this year, which gives us time to adjust our strategy once we have clarity. Now let me discuss how we are incorporating the PTC into our disclosures. Slide 13 provides our gross margin update based on prices at year-end. In 2023, total gross margin is projected to be $8.35 billion, up $100 million from last quarter, lifted by higher power new business targets as we are seeing additional opportunities on the back of the strong performance in 2022. We are introducing our 2024 gross margin forecast of $8.95 billion, up $600 million from 2023. This is largely due to the timing of our hedges and higher prices. With this update, we have added a road to the bottom of our gross margin table for 2024 when the PTC program goes into effect. As you know, we're still waiting on final ruling of interpretation from Treasury around the nuclear PTC, but we want to provide some insight into the financial impact. So let me explain what this line is and what it is not. This line represents the PTC value we would expect to generate from our plants that do not have state support, so the Pennsylvania and Maryland units as well as LaSalle and Illinois, and using the more conservative spot price methodology that calculates the PTC value without consideration of hedges. In this representation, we will use the forward 2024 prices at each update to determine whether PTCs would be generated. Since we are still in conversations with the states around existing programs, we have not included those units in this analysis. With price at December 31 above the $43.75 PTC floor that I discussed just a moment ago, we do not currently forecast PTC contributions in 2024, which is why there is no PTC revenues in this line on the table. We will plan to use this approach for addressing the PTCs with each quarterly update as we work to reach clarity on final implementation and Treasury and outstanding issues with the state programs. After we have resolution on these issues, we will look to have a more substantive overhaul of our disclosures to best reflect the value and importance of the PTC to our business. Turning to Slide 14. We provide an updated view of our CapEx outlook through 2025. As Joe mentioned, we are making investments to derisk our business and set us up to create long-term value. Our CapEx plans have increased from the '22 Analyst Day with investments in the mid $2 billion for the next 3 years. The majority of the increase can be attributed to the $1.5 billion of organic growth projects, increased nuclear fuel spend and an increase in baseline CapEx, largely around timing. I will use the next 2 slides to talk through where we are seeing increases and why. Moving to Slide 15. I'm excited to provide further details on the $1.5 billion of growth investments we are pursuing with each opportunity exceeding our double-digit unlevered return threshold. The IRA was transformational in many ways, including by allowing us to accelerate some projects where the economics are extremely compelling. We continue to believe that hydrogen produced nuclear plants will play a critical role in addressing climate change by helping to decarbonize hard-to-decarbonize sectors. We have spent considerable time over the last year exploring how we could play a role in the hydrogen economy and create value for our business and our owners. Nine Mile Point is the first -- was the first in the country to produce hydrogen from nuclear power. We are active participants in the hub in the Midwest, the Mid-Atlantic hub and the Northeast hub, with ease exploring commercial applications for hydrogen alongside nuclear-powered stations. We plan to deploy approximately $900 million of capital towards building a first-of-its-kind commercial scale, greenfield hydrogen production facility in the Midwest. This facility will initially have a capacity of 250 megawatts, the equivalent of producing approximately 33,450 TPA of hydrogen and will be built for ready expansion to 400 megawatts. Approximately 90% of the hydrogen produced is expected to be sold through offtake agreements with customers who will be co-located at our facility. And as Joe has said, we expect to announce commercial deals in the coming months. We are in the early stage design -- early design stages of this project. Procurement of the appropriate equipment, construction and commissioning will take some time. We expect the facility to be in commercial operation in 2026. The support for nuclear in the IRA has also made extending the lives of nuclear assets to 80 years more likely assuming continued support. It has also caused us to relook at nuclear upgrade opportunities that had been shelved a decade ago. The tax credit starting at $27.50 per megawatt hour for the production of new carbon-free electricity provides opportunities for us to expand the capacity at our plants. As a result, we have decided to pull forward planned turbine replacements in Byron and Braidwood and take advantage of the upgrade opportunity in the IRA by committing approximately $800 million from 2023 to 2029, demonstrating our firm commitment to preserving and enhancing our world-class fleet. Approximately $600 million of the spend was already embedded in our long-term plan towards the end of the decade. You can now see this step up in baseline CapEx on the prior slide beginning in 2023. With our work to replace the aged turbines, we will invest an additional $200 million to fund even more efficient models and install higher efficiency, high-pressure turbines to gain additional capacity. These projects utilize the latest turbine technologies to address aging issues, increase operational reliability and reduce future turbine inspection frequency and duration. In total, we will increase the asset of Byron and Braidwood by 135 megawatts. Turbines are long lead parts and will be installed during scheduled outages between 2026 and 2029 with increase in capacity coming from each round of work. We're continuing to evaluate other nuclear uprate opportunities and we'll provide updates on additional investments as we validate the scope of work and appropriate economics. Finally, on growth, let me turn to our opportunities for wind repowering and refurbishing that Bryan talked about at the Analyst Day, we've identified $350 million of investments for approximately 315 megawatts. These projects have low risk of execution, will qualify for new PTCs and will make the existing sites more efficient to generate greater output at the same wind conditions. The first 70-megawatt parcel repowering is expected to be in commercial operation this year. We're excited about these growth prospects, supporting our commitment to be a leader in advancing clean energy goals and earning appropriate returns on our investment. We see these investments they first step and will continue to explore additional opportunities that meet our double-digit unlevered return thresholds while remaining disciplined in our decisions. Turning to nuclear on Slide 16. In response to the Russian-Ukraine conflict, our nuclear fuels team has worked diligently over the past year using their deep relationships and buying power to secure enough nuclear fuel inventory and future contracts to meet our needs through 2028 even as existing contracted Russian fuel supply was disrupted. This inventory build will bridge our new fuel supply from now through 2028, at which point, multiple Western providers have stated they are able to have additional supply online. The incremental fuel buying is driving much of the CapEx increase with the remainder primarily due to sharply higher prices for uranium enrichments and conversion services as a result of the conflicts. We believe this is a prudent allocation of capital to ensure operating reliability given supply uncertainty. From a P&L perspective, since fuel in our operating expenses over time, we're forecasting year-over-year inflation and fuel costs but at levels still below $6 per megawatt hour when we get after the 2028 time period. We continue to work with the administration, Congress and other stakeholders to facilitate the expansion of domestic enrichment and conversion facilities within the United States to improve the security of nuclear fuel and its contribution to meeting our nation's carbon goals. Turning to O&M on Slide 17. Our costs have moved up but are generally flat across the disclosure period, setting the new baseline for costs for our current operations. These updates require some context to help better understand what we are seeing. When I look at the increase, there are several major buckets driving the changes from last year. First, starting with growth-related expenses. We talked previously about the need to ramp our spending on growth to support all the strategies we've been talking about over the past year and that are starting to bear fruit with the announced CapEx. This number will vary by year, but will remain less than 1% of our total O&M budget. Two, we have an increase in cost but also have revenue offsets captured in our top line forecast. The conversion of growth investments into contributing projects will have associated O&M costs, including the big capital projects we just talked about like hydrogen, but also spending on initiatives of commercial that are capital-light, for example, our core growth strategy but have profitable revenue contributions. We're also anticipating higher future bad debt expense with higher prices and what are more predictable default rates, but we've been adjusting our pricing to reflect this higher cost. As our growth investments come online, you should reasonably expect O&M increases that are more than captured with higher revenues. Three, as we discussed on the last call, although we had some labor and supply inflation productions, we are not immune from inflationary pressures or the impacts of restaffing our workforce during these highly competitive times. As Joe said, the deep work at Constellation the key to our success and ensuring that we not only attract the best talent but retain them is paramount. To do this, we must be competitive with our paid benefits. Fourth, the CMC saved the plants retirement for 5 years and the IRA now gives us greater confidence that these plants and the entire fleet will continue to operate for 80 years with continued policy support. Prior to the IRA passage, we're always looking over our shoulders about how long some of our units would run beyond existing state support mechanisms, and we're understandably making decisions on the level of investment in cost based on life expectancy. We have reversed those decisions, and as a result, they are contributing to some O&M increase from Analyst Day. When we look at the long-term value of these assets, we believe the additional spending is appropriate. And finally, we've learned a lot over the course of the year as our first year as a stand-alone company. We have found that some of our support cost assumptions were not sufficient to support our base business, let alone one poised to take advantage of our future opportunities. Turning to Slide 18, we show our projected credit metrics for 2023, which remains firmly in the mid- to high BBB equivalent range. At S&P, we are rated BBB and remain on positive outlook following our recent upgrade and remain Baa2 at Moody's with a stable outlook. The investment grade balance sheet continues to bring value and provide competitive advantages in today's markets, positioning us well as we head into 2023. Our balance sheet, along with our debt maturity profile with a weighted average maturity of 13 years, provides us flexibility as we continue to look to grow our best-in-class fleet both organically and inorganically. It provides us with more opportunities to transact in volatile commodity markets where margins expand as risk is more appropriately reflected in pricing, and we are better positioned to service our customers, all while meeting our liquidity needs. Turning to Slide 19. Let's talk about our capital allocation plans for the next 2 years covering 2023 and 2024. Starting on the left, we forecast approximately $4 billion in free cash flow before growth after absorbing the increase in base CapEx and nuclear fuel that I covered earlier. Moving to the right, we continue to manage our balance sheet to our 35% CFO to debt target, which with the increase in earnings and cash flow, affords us about $800 million of debt capacity after higher net collateral requirements. Collectively, we have approximately $5 billion of cash available for allocation. Approximately $200 million will go towards the remaining capital and O&M spend related to the separation and for the ERP system implementation with the rest then going to our value creation and return commitments we've been discussing today. Nearly $800 million will be returned to our owners with the doubling of the common dividend this year, growing 10% next year and beyond. $1 billion of the $1.5 billion of growth CapEx will be deployed over these 2 years, again, with returns exceeding our double-digit unlevered threshold. We then plan to return another $1 billion to owners through buybacks. That leaves us with approximately $2 billion of unallocated capital over the next 2 years. This unallocated capital provides us with flexibility to pursue our strategic priorities, including nuclear M&A and additional organic growth as long as those projects meet our return thresholds. And as you're seeing today, if those opportunities don't materialize, we'll return the capital to our owners. Thank you all for your time today. We look forward to another strong year in delivering on our financial commitments, and I'll now turn the call back to Joe.